Promoter & Managing Director
Ms. Ameera Shah is the Promoter & Managing Director of Metropolis Healthcare Ltd., a reputed chain of pathology labs with a loyal customer base across India, South Asia, and Africa. Metropolis is rated amongst the top 1% laboratories globally for its quality systems and protocols. Under the leadership of Ms. Shah, Metropolis listed successfully at the stock exchanges in April 2019 at a 9% premium amidst challenging market circumstances. Ms. Shah led Metropolis into the frontlines of the COVID testing in India apart from advising and engaging with the Indian Government to plan a response for the pandemic. Metropolis today has 15 approved and audited COVID Labs across the country and performs thousands of COVID tests each day.
For the last 20 years, Ms. Shah has focused on delivering sustained growth, built, and led corporate functions, including finance, strategy, business process optimization, innovation, investor relations etc. Under her leadership, Metropolis raised the bar of diagnostic accuracy, technological equipment, customer experience and research driven, empathetic service. Ms. Shah has led the corporate= transformation of Metropolis by setting protocols, hiring expert professionals for the management team, and bringing together a fully actualized board. Due to its unique growth model and competitive advantage, Metropolis has attracted three rounds of investment by reputed private equity investors. Upholding the highest standards of corporate governance and business ethics, Metropolis has built exceptional value for all its stakeholders.
Named amongst ‘Asia’s Power Businesswoman’ (2020) by Forbes Asia, ‘Fifty Most Powerful Women in Business’ by Fortune India (2017, 2018, 2019, 2020) and Business Today (2018, 2019), Ms. Shah is recognized as a global thought leader in the healthcare industry. She has also played an instrumental role in changing the pathology industry landscape in the country; from being a doctor led practice to a professional corporate group in an extremely unregulated, competitive, and fragmented market. Ms. Shah received a degree in Finance from The University of Texas at Austin and is an alumnus of the Harvard Business School (OPM Program)
In addition to being a propagator of organizational empathy and gender sensitivity, Ms. Shah is also an active financial investor and a business mentor. Passionate about the women leadership and empowerment, she has committed to supporting budding women entrepreneurs. This led her to set up Empoweress in 2017, a not-for-profit platform for women-led businesses to find advice, mentorship, and micro-funding.
An eminent industry spokesperson, she has been featured as a speaker in various National and International forums, industry events and conclaves organized by IIM, Harvard Business School, TedX, CII, FICCI, Twitter amongst others. She has also been elected the Secretary of the IAPL (Indian Association of Pathology Laboratories) and has served as the Chairperson of the ‘FICCI Health services Western Subgroup’ that drives policy decisions at the Center.
Ms. Shah is an independent director on the board of reputed Indian companies (Marico Kaya, Torrent Pharma, Shoppers Stop) and is also an advisor to Baylor College of Medicine, Texas. She is also on the global advisory board of AXA, a Paris headquartered company with 700 Billion $ under asset management.
Notable Awards and Accolades